Miguel
Cervero Jiménez
Hospital Severo Ochoa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Severo Ochoa (48)
2024
-
Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile
Open Forum Infectious Diseases, Vol. 11, Núm. 4
2023
-
HIV medical care interruption among people living with HIV in Spain, 2004-2020
AIDS, Vol. 37, Núm. 8, pp. 1277-1284
-
Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study—The U-SEX-2 GESIDA 9416 Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
2022
-
Amikacin pharmacokinetics in elderly patients with severe infections
European Journal of Pharmaceutical Sciences, Vol. 175
-
Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial
Frontiers in Pharmacology, Vol. 13
-
Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Vol. 150, pp. 112965
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
Medicine (United States), Vol. 101, Núm. 24, pp. E29252
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
-
Reply: «Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure»
Medicina Clinica
2021
-
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
Frontiers in Immunology, Vol. 12
-
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity
Frontiers in Immunology, Vol. 12
-
Late HIV diagnosis among immigrants in Spain vs. native-born Spaniards, 2010-15
European Journal of Public Health, Vol. 31, Núm. 6, pp. 1123-1128
-
Mortality in Perinatally HIV-infected Adolescents after Transition to Adult Care in Spain
Pediatric Infectious Disease Journal, Vol. 40, Núm. 4, pp. 347-350
-
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy
Biochemical Pharmacology, Vol. 192
2019
-
Efficacy of an information system addressed to nursing staff for diminishing contaminated blood cultures: A blind clinical trial
Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 130-136
2018
-
Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients
PLoS ONE, Vol. 13, Núm. 4
-
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study
PLoS ONE, Vol. 13, Núm. 6
-
Risk factors and clinical evolution of carbapenemase-producing klebsiella pneumoniae infections in a university hospital in Spain. Case-control study
Revista Espanola de Quimioterapia, Vol. 31, Núm. 5, pp. 427-434
2017
-
Dual Therapy with Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy with Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial
Clinical Infectious Diseases, Vol. 65, Núm. 12, pp. 2112-2118